IL161501A0 - Methods of preventing and treating flavivirus infection in animals - Google Patents

Methods of preventing and treating flavivirus infection in animals

Info

Publication number
IL161501A0
IL161501A0 IL16150102A IL16150102A IL161501A0 IL 161501 A0 IL161501 A0 IL 161501A0 IL 16150102 A IL16150102 A IL 16150102A IL 16150102 A IL16150102 A IL 16150102A IL 161501 A0 IL161501 A0 IL 161501A0
Authority
IL
Israel
Prior art keywords
animals
preventing
methods
flavivirus infection
treating flavivirus
Prior art date
Application number
IL16150102A
Other languages
English (en)
Original Assignee
Acambis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acambis Inc filed Critical Acambis Inc
Publication of IL161501A0 publication Critical patent/IL161501A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL16150102A 2001-10-19 2002-10-21 Methods of preventing and treating flavivirus infection in animals IL161501A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34684501P 2001-10-19 2001-10-19
PCT/US2002/033795 WO2003063725A2 (en) 2001-10-19 2002-10-21 Methods of preventing and treating flavivirus infection in animals

Publications (1)

Publication Number Publication Date
IL161501A0 true IL161501A0 (en) 2004-09-27

Family

ID=27662959

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16150102A IL161501A0 (en) 2001-10-19 2002-10-21 Methods of preventing and treating flavivirus infection in animals
IL161501A IL161501A (en) 2001-10-19 2004-04-19 Use of a chimeric flavivirus in the preparation of a medicament for preventing or treating flavivirus infection in a horse

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161501A IL161501A (en) 2001-10-19 2004-04-19 Use of a chimeric flavivirus in the preparation of a medicament for preventing or treating flavivirus infection in a horse

Country Status (20)

Country Link
US (1) US6878372B2 (xx)
EP (1) EP1441761B1 (xx)
JP (2) JP5164305B2 (xx)
KR (3) KR20040052245A (xx)
AT (1) ATE359816T1 (xx)
AU (1) AU2002365922B2 (xx)
BR (1) BR0213408A (xx)
CA (1) CA2464138C (xx)
CY (1) CY1107439T1 (xx)
DE (1) DE60219658T2 (xx)
DK (1) DK1441761T3 (xx)
ES (1) ES2284984T3 (xx)
IL (2) IL161501A0 (xx)
MX (1) MXPA04003692A (xx)
NZ (1) NZ532385A (xx)
PT (1) PT1441761E (xx)
RU (1) RU2313367C2 (xx)
SI (1) SI1441761T1 (xx)
WO (1) WO2003063725A2 (xx)
ZA (1) ZA200403047B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962708B1 (en) * 1997-02-28 2005-11-08 Acambis, Inc. Chimeric flavivirus vaccines
AU2002309508A1 (en) * 2001-03-12 2002-09-24 L2 Diagnostics, Llc Compositions and methods comprising west nile virus polypeptides
PL371187A1 (en) 2001-06-01 2005-06-13 Acambis, Inc. Chimeric flavivirus vectors
CN103555669B (zh) 2002-01-15 2017-10-13 赛诺菲巴斯德生物制剂有限责任公司 黄病毒疫苗
US20050002968A1 (en) * 2002-01-15 2005-01-06 Monath Thomas P. Flavivirus vaccines
KR101150584B1 (ko) * 2002-11-15 2012-06-27 사노피 파스테르 바이오로직스 씨오 웨스트 나일 바이러스 백신
CA2612047C (en) * 2005-06-24 2015-05-12 Intervet International B.V. Inactivated chimeric vaccines and related methods of use
US8017754B2 (en) * 2005-07-22 2011-09-13 Research Development Foundation Attenuated virus strains and uses thereof
AU2009287449B2 (en) 2008-08-29 2015-04-30 Boehringer Ingelheim Animal Health USA Inc. West nile virus vaccine
WO2010085358A2 (en) * 2009-01-23 2010-07-29 The Board Of Regents Of The University Of Texas System Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof
BR122019023542B1 (pt) 2011-03-14 2022-02-15 Boehringer Ingelheim Vetmedica, Inc Composição imunogênica compreendendo uma ou mais cepas de vírus da rinite equina b (erbv) inativado e seu método de preparação
KR101868554B1 (ko) 2016-10-18 2018-06-19 강원대학교산학협력단 브루셀라 어보투스 ba15 변이주 및 이를 포함하는 브루셀라병 예방용 백신 조성물
GB201716222D0 (en) * 2017-10-05 2017-11-22 Univ Leuven Kath Chimeric Flavivirus Vaccines
CN113372441B (zh) * 2018-04-04 2023-03-10 中国科学院微生物研究所 一种高灵敏度的黄热病毒人源单克隆抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184024B1 (en) * 1988-07-14 2001-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and/or growth-restricted flaviviruses
ES2140418T3 (es) 1991-09-19 2000-03-01 Us Health Flavivirus quimericos y/o flavivirus de crecimiento restringido.
IL131600A0 (en) * 1997-02-28 2001-01-28 Ora Vax Inc Chimeric flavivirus vaccines
AU1813901A (en) 1999-12-01 2001-06-12 Oravax, Inc Chimeric flavivirus vaccines

Also Published As

Publication number Publication date
EP1441761B1 (en) 2007-04-18
CA2464138A1 (en) 2003-08-07
KR20100092038A (ko) 2010-08-19
CY1107439T1 (el) 2012-12-19
BR0213408A (pt) 2004-11-03
JP5164305B2 (ja) 2013-03-21
CA2464138C (en) 2013-08-13
KR101131579B1 (ko) 2012-03-30
DK1441761T3 (da) 2007-08-27
SI1441761T1 (sl) 2007-08-31
KR20120016315A (ko) 2012-02-23
DE60219658T2 (de) 2008-01-03
US6878372B2 (en) 2005-04-12
EP1441761A2 (en) 2004-08-04
JP2005516974A (ja) 2005-06-09
ES2284984T3 (es) 2007-11-16
RU2313367C2 (ru) 2007-12-27
ATE359816T1 (de) 2007-05-15
RU2004115107A (ru) 2005-04-20
ZA200403047B (en) 2005-06-29
WO2003063725A3 (en) 2003-10-30
KR20040052245A (ko) 2004-06-22
WO2003063725A2 (en) 2003-08-07
PT1441761E (pt) 2007-07-16
DE60219658D1 (de) 2007-05-31
JP2010215647A (ja) 2010-09-30
US20030129201A1 (en) 2003-07-10
EP1441761A4 (en) 2004-12-29
NZ532385A (en) 2007-01-26
MXPA04003692A (es) 2005-04-08
AU2002365922B2 (en) 2007-11-22
IL161501A (en) 2010-05-17

Similar Documents

Publication Publication Date Title
CY1107439T1 (el) Μεθοδοι προληψης και θεραπειας μολυνσης απο ιο του γενους flavivirus σε ζωα
HK1073608A1 (en) Treatment of alpha-galactosidase a deficiency
MXPA03007816A (es) Calzoncillo desechable y metodo para proporcionar el mismo.
WO2003101397A3 (en) Tetravalent dengue vaccines
WO2003103571A3 (en) VACCINES AGAINST FLAVIVIRUSES
HK1080382A1 (en) Compositions and methods for treatment of hyperplasia
MXPA03007881A (es) Bacterias productoras de acido lactico para tratar y prevenir la alergia.
HK1074005A1 (en) Compositions and methods for treating or preventing pneumococcal infection
MXPA03010327A (es) USO DE OSTEOPONTINA PARA TRATAMIENTO Y/O PREVENCIoN DE ENFERMEDADES NEUROLoGICAS.
HUP0401808A3 (en) Dosage forms, devices and methods of treatment
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
ATE383874T1 (de) Perylenequinonen zur anwendung als sonosensitizer
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
WO2002024223A3 (en) Prevention and treatment of streptococcal and staphylococcal infection
WO2003096877A3 (en) Prevention and treatment of streptococcal and staphylococcal infection
ZA200204018B (en) Combination treatment for depression and anxiety.
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
MXPA03009228A (es) Uso de proteina uk 114 o de fragmentos de la misma para tratamiento y prevencion de choque endotoxico.
ZA200107183B (en) Treatment of denim and other garments.
UA32314A (uk) Спосіб лікування некротичного панкреатиту